
Networking 101: Schmooze It or Lose It!
Includes a Live Web Event on 10/07/2025 at 12:00 PM (EDT)
-
You must log in to register
- Member - Free!
ACoP is less than two weeks after this webinar, and for many, the excitement about the impending conference may be tamped down by the dread of having to NETWORK (!!). But fear not - help is at hand!
Networking is for *everyone*, not just extroverts. In this webinar, what networking is (and isn't) will be defined, and you will be shown some tips and tricks for preparing and executing a networking plan for in-person events. You will also learn to develop conversation prompts to foster meaningful engagements. And while in-person events are great to build relationships, your network needs consistent attention year-round! How to navigate the virtual world and maintain real connections, despite the technological barriers will be discussed, and you will understand how social media can help you to stay connected and visible, and to build your brand … all with authenticity.
Building and nurturing your professional network is critical to success, especially in a field as small and collaborative as pharmacometrics. This webinar will help you develop meaningful connections, and schmooze with confidence!

Stacey Tannenbaum, PhD, FISoP
Stacey Tannenbaum, PhD, FISoP is a scientist and leader in Model Informed Drug Development, and principal at SJTPharm LLC. She is currently a Consultant and Coach to the MIDD community, supporting the development of leadership, communication, and change management skills.
Her previous roles include VP of Scientific Engagement at Metrum Research Group, and Pharmacometrics science and leadership at Novartis and Astellas. Stacey earned a BSE in Biomedical Engineering (Duke University), a PhD in Pharmaceutical Sciences and Applied Mathematics (University of Arizona), and a post-doctoral fellowship at the Center for Drug Development Science (Georgetown University). During her 25+ years as a PKPD scientist in Pharma and consulting, Stacey contributed to multiple drug development programs and successful submissions. Some of the outcomes of her work were optimization of dosing for future trials and labels, prediction of efficacy and safety with confidence, design of smarter studies and identification of key covariates, and bridging across populations, such as from healthy subjects to patients, and adults to children. As she transitioned from individual contributor into leadership roles, her expertise expanded beyond the science itself to include: championing science communication and soft skills development within technical teams, building infrastructure and implementing best practices for efficient and reproducible MIDD, guiding partners in translating clinical needs into strategic and model-informed solutions, and mentoring and training the next generation of leaders.
Stacey has had a significant impact on the global Pharmacometrics community. She co-founded ISoP, serving as its first President, and is an ISoP Fellow and Leadership Award recipient. Stacey co-founded the ACoP and was conference chair for the first three events; she remains an active volunteer in both ISoP and ACoP. She is the Executive Committee chair for WCoP, and is the chair of the Quantitative Pharmacology Network at ASCPT. She served as a board member of AAPS, chaired the AAPS M&S Focus Group, and was the co-chair for the AAPS Forum for Connecting Predictive Modelers. Stacey also co-founded the networking group Modeling and Simulation Applications in Clinical Pharmacotherapy (MoSAiC), now ISoP-NJ/NY/PA.